BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

VisualMED Clinical Solutions Corp. Provides Quarterly and Year End Revenue Guidance


7/6/2011 10:09:30 AM

RENO, NV--(Marketwire - July 06, 2011) -

VisualMED Clinical Solutions Corp. (The "Company") (PINKSHEETS: VMCS) (FRANKFURT: VA6.F) announces today that it is expecting its revenues for the quarter ended June 30th, 2011 to rise to an amount between $890,000 and $965,000. This constitutes the most revenue in a single quarter in more than four years and represents a significant increase from the same quarter a year ago. These banner figures do allow the Company to provide further guidance regarding year end revenues for the entire exercise which is expected to reach as much as $1.2M to $1.3M.

Final year end results will be released during the last week of August. The Company is planning to hold a conference call immediately after filing 2011 year end results. This conference will be open to all investors and will address the 2011 financial results. Contact information will be provided on company website.

Company Chairman, Mr. Gerard Dab attributes the rising revenue trend to early adopters who desire to move forward ahead of the curve in seeking advanced medical informatics. The administration has been particularly proactive in pushing for better quality of healthcare delivery to patients in American healthcare facilities. For the first time general market conditions appear to favor the kind of advanced medical technology VisualMED offers.

ABOUT VISUALMED
VisualMED markets smart Clinical Information Systems (CIS) with EHR and Computerized Physician Order Entry that are at the core of the new regulatory environment ushered in by the American Recovery and Reinvestment Act of 2009 and the Health Reform Act of 2010. We offer medical facilities and physicians a broad array of clinical applications with rich embedded clinical data, both scalable and interoperable, and whose high level of usability has been tested by over one thousand clinicians over many years in tertiary care and ambulatory environments. Our solutions help medical facilities increase provider efficiency, bring down operating costs, demonstrate meaningful use for ARRA grants and subsidies, and reduce mortality and morbidity. The Company's Suites of Medical Solutions operate on state of the art proprietary software platforms with advanced analytical capabilities provided by Visual Healthcare Corp. (NASDAQ OTC: VSHC).

Detailed information on our company and its products is available on our web site at www.visualmedsolutions.com

FORWARD-LOOKING STATEMENTS Except for historical information provided herein, this press release may contain information and statements of a forward-looking nature concerning the future performance of the Company. These statements are based on suppositions and uncertainties as well as on management's best possible evaluation of future events. Such factors may include, without excluding other considerations, fluctuations in quarterly results, evolution in customer demand for the Company's products and services, the impact of price pressures exerted by competitors, and general market trends or economic changes. As a result, readers are advised that actual results may differ from expected results.


For further information, please contact:

FREDERICK BERLIN
SALES MANAGER
TEL: 514 836 1212 or 514 582 5220


Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->